Excipients

Pharmaceutical excipients, which can be functional or inactive ingredients, work to enhance the medically relevant properties of the API. When used to promote ingredient qualities, excipients can be an asset for formulators to increase stability, bulk up the formulation, or enhance the therapeutic effects of the API. Below you can explore helpful resources including editorial coverage and webinars related to pharmaceutical excipients.

  • Defining VHP Sterilization and Biodecontamination – Common Denominators and Differences

    VHP Applications History VHP has decades of successful use as a bio-decontamination process in the pharmaceutical industry and as a sterilization process in the medical device industry. This article will discuss the similarities and differences between VHP decontamination and sterilization processes, the regulatory standards that govern each method... read more

  • Executive Q&A: Biopharmaceuticals/ Biosimilars

    The market need is the main driver. Today, access to quality Biologics drugs is limited to a minority of the patients around the world. Increasing the supply of biosimilars worldwide should contribute to making based treatment more available. read more

  • Pharmaceutical P.I.N. Points: Patent Innovation News - Nov/Dec 2024

    The purpose of this column is to highlight and summarize recent key patents in the pharmaceutical arena issued by the US Patent Office in August-September, 2024. read more

  • Don’t Stop Thinking About Tomorrow

    My initial exposure to sterile product manufacturing was back in 1973 when I first observed the aseptic filling of small volume parenterals. The image is one the reader is likely quite familiar with: aseptically garbed operators wearing face masks, goggles and sterile gloves separated from a filling line covered by HEPA filters by flexible curtains... read more

  • Disinfect, Autoclave or Use Multiple-Bagged Disposables? Moving Materials into Controlled Areas Safely and Efficiently

    Transferring equipment into and out of cleanrooms and critical zones has proven to be one of the greatest sources of contamination in the manufacture of sterile pharmaceuticals. To minimize the potential for adverse effects on patients, cGMP and EU GMP regulations have been tightened. Transfer procedures are complex, with materials typically having... read more

  • Process Capability to Ensure Product Quality

    Quality by Design (QbD) is a concept first developed by the quality pioneer Joseph M. Juran. Juran believed that quality should be designed into a product and that most quality crises and problems relate to how a product was designed in the first place. A high-quality drug product is a product free of contamination and reliably delivers the ... read more
Page
Page

Webinars

  • <<
  • >>